Clinical trial

The Effect of the Anticholinergic Burden on Complications and Mortality Following Elective Coronary Artery Surgery in Patients Over 60 Years

Name
AnkaraCHBilkent.1
Description
Many drugs have anticholinergic activity. This means that it blocks the muscarinic binding of the neurotransmitter acetylcholine. In this study, the anticholinergic burden of the patients in the perioperative period will be calculated with the Anticholinergic Cognitive Burden Scale (ACBS) and patients with a score of 1 or above will be included in the study. Anticholinergic load of drugs used in the intraoperative period; Its effect on postoperative hospital stay, morbidity and mortality following elective heart surgery will be investigated.
Trial arms
Trial start
2024-01-01
Estimated PCD
2024-12-01
Trial end
2024-12-30
Status
Recruiting
Phase
Early phase I
Treatment
reducing anticholinergic burden
In the intraoperative and postoperative periods instead of drugs with high anticholinergic burden; drugs with low burden will be preferred.
Arms:
Remifentanyl, Propofol, Sevoflurane / Desflurane, Propofol
Size
120
Primary endpoint
Mortality
Postoperative 90 days
Eligibility criteria
Inclusion Criteria: * Patients undergoing elective coronary artery bypass surgery * Patients with high anticholinergic burden Exclusion Criteria: * All other procedures except isolated coronary bypass surgery * Patients with low anticholinergic burden * Patients whose records cannot be accessed through the data system
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 120, 'type': 'ESTIMATED'}}
Updated at
2024-04-05

1 organization

1 product

2 indications

Indication
Mortality